trastuzumab,neratinib
roche,knight therapeutics,pierre fabre,puma
['summit', 'neratinib', 'puma', 'pbyi', 'biotec']
$pbyi puma biotechnology presents final results from the biliary tract cohort of the phase 2 summit basket trial of neratinib at the asco 2022 annual meeting #biotech stock news alerts in bio
Over 500 members. DM us for our premium stock alerts.